The pharmacologic properties and sequences of OPN-R3 aptamer (APT) and mutant aptamer (MuAPT) have been previously published.28 (link)Recombinant human OPN and TGF-β1 proteins (R&D Systems, Minneapolis, MN); αvβ3 integrin and CD44 Abs (Santa Cruz Biotechnology, Santa Cruz, CA); Arg-Gly-Asp (RGD), Arg-Gly-Glu (RGE) (Sigma-Aldrich, St Louis, MO); SB431542 a TGF- β1 type I receptor inhibitor (EMD Millipore, Billerica, MA); TGF-β1 type II receptor shRNA (Santa Cruz Biotechnology); MZF1 siRNA (Life Technologies, Carlsbad, CA); and Control siRNA81 (link): UAAGGCUAUGAAGAGAUAC were all obtained.
Recombinant human opn and tgf β1 proteins
Manufactured by R&D Systems
Recombinant human OPN and TGF-β1 proteins are purified, biologically active proteins produced in a cell expression system. OPN is a glycoprotein involved in bone mineralization and immune regulation. TGF-β1 is a multifunctional cytokine that regulates cell growth, differentiation, and other functions.
Automatically generated - may contain errors
2 protocols using recombinant human opn and tgf β1 proteins
1
Exploring OPN-R3 Aptamer Interactions
2
Exploring OPN-R3 Aptamer Interactions
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!